©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Sep 21, 2015; 21(35): 10062-10071
Published online Sep 21, 2015. doi: 10.3748/wjg.v21.i35.10062
Published online Sep 21, 2015. doi: 10.3748/wjg.v21.i35.10062
Coagulopathy in liver disease: Lack of an assessment tool
Annabel Blasi, Anesthesia Department, Hospital Clínic, Institut d´investigacions Biomediques Agustí Pi i Sunyer, 08037 Barcelona, Spain
Author contributions: Blasi A solely contributed to this work.
Conflict-of-interest statement: The author declares no conflicts of interest.
Correspondence to: Annabel Blasi, MD, Anesthesia Department, Hospital Clínic, Institut d´investigacions Biomediques Agustí Pi i Sunyer, 08037 Barcelona, Spain. annnabelb@gmail.com
Telephone: +34-932-275558 Fax: +34-932-279184
Received: April 6, 2015
Peer-review started: April 7, 2015
First decision: May 18, 2015
Revised: May 29, 2015
Accepted: August 25, 2015
Article in press: August 25, 2015
Published online: September 21, 2015
Processing time: 166 Days and 14.5 Hours
Peer-review started: April 7, 2015
First decision: May 18, 2015
Revised: May 29, 2015
Accepted: August 25, 2015
Article in press: August 25, 2015
Published online: September 21, 2015
Processing time: 166 Days and 14.5 Hours
Core Tip
Core tip: The lack of comprehensive tests to assess coagulopathy in liver disease ties the management of this disease to the clinical evidence. This review considers the information provided by clotting tests in cirrhotic patients, identifies clinical evidence on which to base the management of the disease, and considers possible future directions of research.